Mamintas, Wenilyn .

HRN: 04-44-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2024
CEFUROXIME 1.5GM (VIAL)
01/16/2024
01/16/2024
IV
1.5g
On Call To OR
Primary LTCS For Placenta Previa Totalis
Waiting Final Action 
01/16/2024
CEFUROXIME 1.5GM (VIAL)
01/16/2024
01/17/2024
IV
1.5g
Q8 X 6 Doses
S/p LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: